Latest Pharma R&D Cost Estimates – Implications For The Expanded Use Of Commercial Analytics

White Paper

Latest Pharma R&D Cost Estimates – Implications For The Expanded Use Of Commercial Analytics

The latest pharma R&D cost estimates illustrate that greater pressures will increasingly be placed on companies to find greater cost efficiencies, reduce risks, improve pipelin ...

Impact Of State Pharmacy Drug Product Selection Laws On Patient Brand - Generic Drug Utilization

White Paper

Impact Of State Pharmacy Drug Product Selection Laws On Patient Brand – Generic Drug Utilization

The pharmacy channel has been an under-studied area by drug companies relative to greater focus on physicians, managed care, hospitals, and patients/consumers. This paper sheds emp ...

Commercial Operations Capabilities Excellence And Business Performance

Blog

Commercial Operations Capabilities Excellence And Business Performance

Pharmaceutical companies spend a substantial amount of money on sales & marketing (S&M). One recent article noted the top 10 pharma companies spent $98.3 billion on S&M ...

The Evidence Supporting Sales Rep Access Restrictions To Physicians – “Where’s The Beef?”

White Paper

The Evidence Supporting Sales Rep Access Restrictions To Physicians – “Where’s The Beef?”

The last 10-15 years have seen an explosion of articles in major health policy and medical journals advocating severely restricting or banning biopharmaceutical sales rep access to ...

Biosimilars In The US - Will They Deliver On The Promise?

Blog

Biosimilars In The US – Will They Deliver On The Promise?

Research presented from Mylan Pharmaceuticals at the recently held 2016 annual meeting of the American Society of Clinical Oncology (ASCO) generated excitement within the medical c ...

Challenges To Traditional Pharma Incentive Compensation Plan Design

White Paper

Challenges To Traditional Pharma Incentive Compensation Plan Design

Changes in emerging environmental trends facing the pharma industry are requiring companies to rethink different strategic and operational sales force plans that ultimately drive n ...

The Pricing Challenge Of Pharma's Shift To Specialty Medicines

White Paper

The Pricing Challenge Of Pharma’s Shift To Specialty Medicines

The shift to specialty medicines has opened up for pharma companies a wealth of opportunities in addressing unmet medical needs of patients and improve the cost of care. This shift ...

White Paper

Measuring Sales Rep-Physician Relationship Disruption In Sales Force Optimization

There is a growing importance of maintaining sales rep-physician relationships and accounting for their disruption in sales force optimization and territory alignment analyses. Thi ...

White Paper

Driver Score – The New Paradigm

Of late, telematics as a disruptive technology is rapidly gaining attention in shaping the future. New industries are accepting this revolution and are moving to data-backed decisi ...

White Paper

At Supplier Management Crossroads? – Choose The Right Approach

Of late, regulators have started focusing attention on the way banks and financial institutions are managing the risk in their supplier management programs. ...

White Paper

Deploying K-Nearest Neighbor Modeling Methodologies For Real World Problems

There has been an immense improvement of theory and algorithms in recent times leading to enhancement in computation power. Also, online data availability was never easier than now ...

White Paper

A Mathematical Framework For Privacy Risk

In recent trends, people’s attitude towards the internet has changed tremendously. The willingness and comfort level of people to share and reveal information about themselves an ...

No more posts to display!

White Paper

Portfolio Stress Testing Methodologies

As the world is crawling out of the global economic crisis, several efforts are underway by regulators as well as international organizations, such as the International Monetary Fu ...